WTF Are You Waiting ForJust another Site 1 Sites site

Whether you are cleaning the garage or attic, clearing the gutters, or raking, it is time for the pre-winter cleanup. No matter the chore, these simple tasks can become a pain in the neck, quite literally. For some ambitious folks, these cleanup days also serve as an excellent time to put up holiday decorations before the first snowfall or family festivity…

Original post: Make Way For The Winter, Time For Holiday Prep

Read the rest of this entry »

Ziehm Imaging’s intuitive SmartVascular software considerably simplifies imaging in vascular surgery. It introduces an entirely new workflow for fast results. This solution raises efficiency levels, eliminates interim C-arm operating steps and automates the imaging processes. SmartVascular is compatible with all Ziehm Vision C-arms and tailored to vascular procedures…

Original post: New SmartVascular Software Optimizes Imaging In Vascular Surgery

Read the rest of this entry »

Asheville (N.C.) Citizen-Times: “Despite intensive efforts to improve patient safety, a six-year study at 10 North Carolina hospitals showed no decline in so-called patient ‘harms,’ which included medical errors and unavoidable mistakes…

Original post: Quality Issues Persist At Hospitals, Plastic Surgery Centers; Use Of CT Scans In ER Increases

Read the rest of this entry »

Washington State Hospital Association is releasing hospital-specific surgical infection rate data. This is the first time this information has been made public. “Washington’s hospitals are enthusiastic participants in providing this new information about surgical infection rates,” said Carol Wagner, vice president for patient safety at the Washington State Hospital Association…

Original post: Hospital Surgery Infection Rates Made Public

Read the rest of this entry »

Syneron Medical Ltd. (Nasdaq: ELOS), the global leader in the medical aesthetic device marketplace, announced today the US Food and Drug Administration (FDA) and Health Canada clearance and commercial launch of its highly flexible CO2RE CO2 resurfacing system…

Original post: Syneron Announces US And Canada Launch Of CO2RE System Following FDA And Health Canada Clearance For The System

Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) have announced that the ADVANCE-3 study results, published in The New England Journal of Medicine, showed apixaban was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total hip replacement surgery…

Original post: Investigational Apixaban ADVANCE-3 Study Demonstrates Statistical Superiority To Enoxaparin In The Prevention Of Venous Thromboembolism